SPL 1.08% 9.4¢ starpharma holdings limited

‘Starpharma has since also met with the FDA to discuss this...

  1. 3,421 Posts.
    lightbulb Created with Sketch. 812
    ‘Starpharma has since also met with the FDA to discuss this submission. Starpharma will provide an update on this submission upon receiving an outcome from the FDA.’

    What the HELL?

    This is a formal dispute resolution process. The FDA will have a mandated number of days and/or agreed date to respond to Starpharma with their decision.

    So where is the date/timeline Starpharma? Why is this not communicated to long-suffering shareholders?

    This is just not good enough and shows to me that the new CEO doesn’t get it either and intends to treat shareholders as mugs and mushrooms as we have been for decades.

    Another red flag for me.
    Last edited by sarge17: 31/01/24
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.4¢
Change
0.001(1.08%)
Mkt cap ! $39.23M
Open High Low Value Volume
9.4¢ 9.5¢ 9.3¢ $29.92K 320.8K

Buyers (Bids)

No. Vol. Price($)
1 149283 9.4¢
 

Sellers (Offers)

Price($) Vol. No.
9.6¢ 100000 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.